Andrew Spaventa | executive |
Dalen Meeter | executive |
Daniel Brennan | analyst |
Jake Allen | analyst |
Good afternoon, everyone, and welcome to the Singular Genomics Fourth Quarter and Full Year 2023 Earnings Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, Philip Taylor. Sir, the floor is yours.
Thank you, operator. Presenting today are Singular Genomics' Founder, Chair and Chief Executive Officer, Drew Spaventa; and the company's Chief Financial Officer, Dalen Meeter. Earlier today, Singular Genomics released financial results for the 3 months ended December 31, 2023.